Compliance & Policies

Key Managerial Personnels

Whole Time Director & CEO

Sachin Srivastava
‎+91 22 4518 2008
[email protected]

Whole Time Director & CFO

Baijoo Madhusudan Raval
‎+91 22 4518 2008
[email protected]

COMPLIANCE OFFICER

Anita Amitkumar Gupta
‎+91 22 4518 2008
[email protected]

Others

Registered Office

Relic Technologies Limited
6, Floor-Grd, Plot-79, Himalaya House,
Ramabai Ambedkar Marg,
Crawford Market, Fort,
Mumbai G.P.O.,
Mumbai – 400001
Tel No. +91 22 4518 2008
CIN: L46497MH1991PLC064323
www.relictechnologies.in

Registrars & Share Transfer Agent

Bigshare Services Private Limited
Office No. S6-2 ,6th Floor,
Pinnacle Business Park,
Mahakali Caves Road,
Andheri East,
Mumbai - 400093
Tel No. +91 22 6263 8200
Email: [email protected]
Website: www.bigshareonline.com

Investor Grievance Officer

Anita Amitkumar Gupta
Company Secretary & Compliance Officer
‎+91 22 4518 2008
[email protected]

Board of Directors and Committees

Mr. Kunal Narendra Gandhi
‎Non-Executive and Non-Independent Director

Mr. Kunal Narendra Gandhi is a seasoned business leader with over 15 years of experience in the pharmaceutical industry, encompassing business strategy, corporate management, business development and international operations. He holds a Master of Science degree from Lancaster University, United Kingdom. He commenced his professional journey in 2010 and has held various leadership positions, including Vice President – Business Development, Chief Executive Officer and Managing Director of Lyka Labs Limited. Throughout his career, he has been instrumental in driving strategic growth initiatives, strengthening domestic and international business, and fostering operational excellence. Mr. Gandhi brings to the Board valuable expertise in corporate strategy, business development, governance and the pharmaceutical sector. His strategic perspective and leadership experience contribute meaningfully to the Board's deliberations and long-term value creation.

Mr. Sachin Srivastava
‎Whole Time Director and Chief Executive Officer (CEO)

Mr. Sachin Srivastava with almost 25 years of experience in pharmaceutical sales and marketing and a seasoned professional with practical experience with wide understanding of the diverse range of pharma business and management. The key roles involve with team building, building brands, branding activities, improving on profits, crafting organization strategy, brand communication and promotion, managers development for effectiveness, evaluation of team and improving on their skills, increasing market share, increasing turnover of the organization and profitability.

Ms. Dhara Pratik Shah
Non-Executive and Independent Director

Ms. Dhara Pratik Shah is a qualified Company Secretary, Law Graduate (LL.B.) and Bachelor of Commerce with over 10 years of experience in the areas of corporate laws, secretarial compliances, legal advisory and corporate governance. She possesses extensive expertise in the Companies Act, SEBI regulations, listing compliances and allied corporate laws. Over the course of her professional career, Ms. Shah has served on the Boards of various listed and unlisted companies in the capacity of an Independent and Non-Executive Director. She brings valuable experience in corporate governance, regulatory compliance, legal and commercial matters, and contributes effectively to the Board's oversight and decision-making processes.

Ms. Neha Anant Thakore
‎Non-Executive and Independent Director

Mrs. Neha Anant Thakore, is Managing Partner of Rifa Pharma, COO of Avik Pharmaceutical Ltd, the leading companies that are at the forefront of revolutionizing healthcare in India. With over 25 years of experience in the Active Pharmaceutical Ingredients (API) industry, Mrs. Thakore has had the privilege of representing esteemed international firms and managing a thriving manufacturing unit. Mrs. Thakore has rich and varied experience in the Pharmaceutical Industry and also serves as the Vice Chairperson of the IDMA Bulk Drug Committee.

Mr. Baijoo Madhusudan Raval
‎Whole Time Director and Chief Financial Officer (CFO)

Mr. Baijoo Madhusudan Raval is a seasoned business professional with over 30 years of experience across capital markets, insurance, business strategy and corporate management. He has been associated with the Board of Relic Technologies Limited for over 15 years and currently serves as its Whole-time Director and Chief Financial Officer. A graduate by qualification, Mr. Raval possesses extensive experience in strategic planning, financial management and business development. Over the years, he has played a significant role in driving business growth, strengthening governance practices and contributing to the formulation and execution of long-term business strategies. Mr. Raval brings to the Board valuable insights in the areas of corporate strategy, finance, capital markets and business operations, which support the Company's long-term growth and governance objectives.

Ms. Radhika Shriram
Non-Executive and Non-Independent Director

Mrs. Radhika Shriram is a double graduate in commerce and education. She has been an entrepreneur and an investor. She has keen interest in Nutritional sciences and pursuing her post-graduation diploma in dietetics & nutrition.

Audit Committee

Ms. Dhara Pratik Shah (Chairperson)

Mr. Kunal Narendra Gandhi

Ms. Neha Anant Thakore

Nomination and Remuneration Committee

Ms. Dhara Pratik Shah (Chairperson)

Mr. Kunal Narendra Gandhi

Ms. Neha Anant Thakore

Stakeholders Relationship Committee

Ms. Dhara Pratik Shah (Chairperson)

Ms. Neha Anant Thakore

Mr. Baijoo Raval

Related Party Transaction Policy
Code of conduct to regulate, monitor and report trading by insiders
Policy for determining ‘material’ subsidiaries
Policy for determination of materiality for disclosure of events or information
Familiarisation Programme for Independent Directors
Policy and Procedure for Inquiry in case of leak of Unpublished Price Sensitive Information (UPSI)
Nomination and Remuneration Policy
Preservation of Documents
Vigil Mechanism and Whistle blower
Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI)
Terms and Conditions of Appointment of Independent Directors

MOA and AOA

Annual Return Form MGT-7 FY 2024 25